Globe Newswire (Mon, 3-Aug 4:05 PM ET)
TipRanks (Mon, 3-Aug 1:35 PM ET)
TipRanks (Mon, 3-Aug 10:50 AM ET)
Market Chameleon (Mon, 3-Aug 6:31 AM ET)
TipRanks (Mon, 3-Aug 10:20 AM ET)
Autolus Raises AUCATZYL Outlook, Secures New Credit Facility
TipRanks (Mon, 3-Aug 8:30 AM ET)
Autolus Secures New $250 Million Financing and Warrants
TipRanks (Mon, 3-Aug 7:31 AM ET)
Globe Newswire (Mon, 3-Aug 7:13 AM ET)
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Wed, 1-Jul 4:05 PM ET)
Autolus Therapeutics to Participate in Upcoming Investor Conference
Globe Newswire (Thu, 25-Jun 7:00 AM ET)
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Autolus Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AUTL.
As of August 6, 2026, AUTL stock price climbed to $2.00 with 3,741,041 million shares trading.
AUTL has a beta of 2.26, meaning it tends to be more sensitive to market movements. AUTL has a correlation of 0.16 to the broad based SPY ETF.
AUTL has a market cap of $531.85 million. This is considered a Small Cap stock.
Last quarter Autolus Therapeutics PLC - American Depositary Shares reported $26 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $57,912 and met earnings estimates .
In the last 3 years, AUTL traded as high as $7.45 and as low as $1.11.
The top ETF exchange traded funds that AUTL belongs to (by Net Assets): IBB, CANC, GWX, QQQS, APIE.
AUTL has underperformed the market in the last year with a return of -15.6%, while SPY returned +23.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AUTL shares. However, AUTL has outperformed the market in the last 3 month and 2 week periods, returning +22.0% and +38.9%, while SPY returned +6.5% and +2.8%, respectively. This indicates AUTL has been having a stronger performance recently.
AUTL support price is $1.81 and resistance is $1.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AUTL shares will trade within this expected range on the day.